BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19523522)

  • 1. Automated quantification of caudate atrophy by local registration of serial MRI: evaluation and application in Huntington's disease.
    Hobbs NZ; Henley SM; Wild EJ; Leung KK; Frost C; Barker RA; Scahill RI; Barnes J; Tabrizi SJ; Fox NC
    Neuroimage; 2009 Oct; 47(4):1659-65. PubMed ID: 19523522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved reliability of hippocampal atrophy rate measurement in mild cognitive impairment using fluid registration.
    van de Pol LA; Barnes J; Scahill RI; Frost C; Lewis EB; Boyes RG; van Schijndel RA; Scheltens P; Fox NC; Barkhof F
    Neuroimage; 2007 Feb; 34(3):1036-41. PubMed ID: 17174572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Segmentation and volumetric analysis of the caudate nucleus in Alzheimer's disease.
    Jiji S; Smitha KA; Gupta AK; Pillai VP; Jayasree RS
    Eur J Radiol; 2013 Sep; 82(9):1525-30. PubMed ID: 23664648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hippocampal volume change measurement: quantitative assessment of the reproducibility of expert manual outlining and the automated methods FreeSurfer and FIRST.
    Mulder ER; de Jong RA; Knol DL; van Schijndel RA; Cover KS; Visser PJ; Barkhof F; Vrenken H;
    Neuroimage; 2014 May; 92():169-81. PubMed ID: 24521851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External evaluation of a deep learning-based approach for automated brain volumetry in patients with huntington's disease.
    Haase R; Lehnen NC; Schmeel FC; Deike K; RĂ¼ber T; Radbruch A; Paech D
    Sci Rep; 2024 Apr; 14(1):9243. PubMed ID: 38649395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. White matter integrity in premanifest and early Huntington's disease is related to caudate loss and disease progression.
    Novak MJ; Seunarine KK; Gibbard CR; Hobbs NZ; Scahill RI; Clark CA; Tabrizi SJ
    Cortex; 2014 Mar; 52():98-112. PubMed ID: 24405816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-Sectional Area Analysis of the Head of the Caudate Nucleus in Huntington's Disease.
    Furukawa F; Ishikawa K; Yokota T; Sanjo N
    Eur Neurol; 2019; 81(1-2):13-18. PubMed ID: 31013498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodal imaging biomarkers in premanifest and early Huntington's disease: 30-month IMAGE-HD data.
    D JF; Stout JC; Poudel G; Churchyard A; Chua P; Egan GF; Georgiou-Karistianis N
    Br J Psychiatry; 2016 Jun; 208(6):571-8. PubMed ID: 26678864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semi-automated basal ganglia segmentation using large deformation diffeomorphic metric mapping.
    Khan A; Aylward E; Barta P; Miller M; Beg MF
    Med Image Comput Comput Assist Interv; 2005; 8(Pt 1):238-45. PubMed ID: 16685851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validating Automated Segmentation Tools in the Assessment of Caudate Atrophy in Huntington's Disease.
    Mansoor NM; Vanniyasingam T; Malone I; Hobbs NZ; Rees E; Durr A; Roos RAC; Landwehrmeyer B; Tabrizi SJ; Johnson EB; Scahill RI
    Front Neurol; 2021; 12():616272. PubMed ID: 33935934
    [No Abstract]   [Full Text] [Related]  

  • 11. Shape analysis of subcortical nuclei in Huntington's disease, global versus local atrophy--results from the TRACK-HD study.
    van den Bogaard SJ; Dumas EM; Ferrarini L; Milles J; van Buchem MA; van der Grond J; Roos RA
    J Neurol Sci; 2011 Aug; 307(1-2):60-8. PubMed ID: 21624624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurochemical correlates of caudate atrophy in Huntington's disease.
    Padowski JM; Weaver KE; Richards TL; Laurino MY; Samii A; Aylward EH; Conley KE
    Mov Disord; 2014 Mar; 29(3):327-35. PubMed ID: 24442623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis.
    Tabrizi SJ; Scahill RI; Durr A; Roos RA; Leavitt BR; Jones R; Landwehrmeyer GB; Fox NC; Johnson H; Hicks SL; Kennard C; Craufurd D; Frost C; Langbehn DR; Reilmann R; Stout JC;
    Lancet Neurol; 2011 Jan; 10(1):31-42. PubMed ID: 21130037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Onset and progression of pathologic atrophy in Huntington disease: a longitudinal MR imaging study.
    Hobbs NZ; Barnes J; Frost C; Henley SM; Wild EJ; Macdonald K; Barker RA; Scahill RI; Fox NC; Tabrizi SJ
    AJNR Am J Neuroradiol; 2010 Jun; 31(6):1036-41. PubMed ID: 20150305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.
    Tabrizi SJ; Reilmann R; Roos RA; Durr A; Leavitt B; Owen G; Jones R; Johnson H; Craufurd D; Hicks SL; Kennard C; Landwehrmeyer B; Stout JC; Borowsky B; Scahill RI; Frost C; Langbehn DR;
    Lancet Neurol; 2012 Jan; 11(1):42-53. PubMed ID: 22137354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease modeling in multiple sclerosis: assessment and quantification of sources of variability in brain parenchymal fraction measurements.
    Sampat MP; Healy BC; Meier DS; Dell'Oglio E; Liguori M; Guttmann CR
    Neuroimage; 2010 Oct; 52(4):1367-73. PubMed ID: 20362675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adaptive local multi-atlas segmentation: application to the heart and the caudate nucleus.
    van Rikxoort EM; Isgum I; Arzhaeva Y; Staring M; Klein S; Viergever MA; Pluim JP; van Ginneken B
    Med Image Anal; 2010 Feb; 14(1):39-49. PubMed ID: 19897403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The progression of regional atrophy in premanifest and early Huntington's disease: a longitudinal voxel-based morphometry study.
    Hobbs NZ; Henley SM; Ridgway GR; Wild EJ; Barker RA; Scahill RI; Barnes J; Fox NC; Tabrizi SJ
    J Neurol Neurosurg Psychiatry; 2010 Jul; 81(7):756-63. PubMed ID: 19955112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated brain iron is independent from atrophy in Huntington's Disease.
    Dumas EM; Versluis MJ; van den Bogaard SJ; van Osch MJ; Hart EP; van Roon-Mom WM; van Buchem MA; Webb AG; van der Grond J; Roos RA;
    Neuroimage; 2012 Jul; 61(3):558-64. PubMed ID: 22480728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fully automated atlas-based MR imaging volumetry in Huntington disease, compared with manual volumetry.
    Kassubek J; Pinkhardt EH; Dietmaier A; Ludolph AC; Landwehrmeyer GB; Huppertz HJ
    AJNR Am J Neuroradiol; 2011 Aug; 32(7):1328-32. PubMed ID: 21680653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.